Cohen, Feeley, Altemose & Rambo
Call Us Today For A FREE Consultation 610-295-5321
Click For A Free Consultation 610-295-5321
Areas of Practice

Recent Study Released on Medical Devices and the FDA Approval Process

Patient safety should be the primary concern when a new medical device is approved for sale.  Medical devices, especially artificial hips, have been in the news quite a bit recently. One of the main reasons for the recent coverage is the recall of the defective DePuy ASR hip replacement system (a product of DePuy Orthopedics, a subsidiary of Johnson & Johnson).  The DePuy ASR device is a metal hip replacement that, in August of 2010, because its unsafe design was causing metal ions to break down and enter the blood stream, leading to metal poisoning in many patients. This massive recall brought to the forefront the issue of FDA approval of devices for sale to patients. Many people were, and still are, unaware that a device such as a hip replacement, can be sold to a patient in the United States without undergoing any real testing by the FDA.  A medical device manufacturer can apply to have a new device approved under something called 510(k) by claiming that the new device is "substantially similar" to a device that the FDA has already approved under its strict pre-market approval process. The Institute of Medicine, www.iom.edu, an independent, nonprofit organization that provides unbiased and authoritative advice, released a study criticizing the FDA approval process (510K). (http://www.iom.edu/Reports/2011/Medical-Devices-and-the-Publics-Health-The-FDA-510k-Clearance-Process-at-35-Years.aspx). Since 510(k) allows a manufacturer to apply to have a device put on the market relatively quickly and without rigorous testing, devices, such as the DePuy ASR hip, are sold to patients without even having been tested in an actual person. The result is that the manufacturers can sell and make profits on their products quicker and without spending money to make them safe - to the great risk and detriment to the public. Patient safety should not take a back seat to quick profits of device manufacturers.  Device manufactures began attacking the report of the Institute of Medicine before it was even released because they knew that the report would be critical of the "fast-track" approval that some devices receive. Fear mongering device manufactures attempt to scare the public by raising baseless concerns about slower access to devices. There is no basis for these fears. As an attorney who has the honor to fight for the rights of victims of the DePuy ASR device, I can tell you that a slight delay that could have helped make this device safer would certainly be worth the trade of having an unsafe device put into a person's body quicker at the expense of their health. It is said that "haste makes waste" but in the medical device world, "haste makes unsafe". Patient safety should be the most important concern when releasing a new device for sale to the public. This is the first of a series of blogs related to Medical Device Study Reports and the FDA approval process.   Jonathan B. Acklen

No Comments

Leave a comment
Comment Information

Take The First Step And Contact Us

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Awards and Memberships

  • who's who legal
  • Global Who's Who Best Lawyers in Pennsylvania
  • Million dollar advocates forum
  • bar register of preeminent lawyers
  • the best lawyers in america
  • the national top 100 trial lawyers
  • national board of trial advocacy est 1977
  • A Proud member of the chamber greater lehigh valley chamber of commerce
  • Super lawyers pennsylvania Super lawyers and Rising stars
  • Best lawyers best law firms us news 2016
  • AV preeminent martindale-hubbell lawyer ratings highest rating

Our Locations

With three Lehigh Valley office locations in Bethlehem, Whitehall and Stroudsburg, we serve clients throughout Pennsylvania and New Jersey. map-image map-image map-image

Bethlehem Office
2851 Baglyos Circle, Suite 200
Bethlehem, PA 18020

Toll Free: 888-854-6895
Phone: 610-295-5321
Fax: 610-332-2722
Bethlehem Law Office Map

Whitehall Office
352 5th Street, Suite C
Whitehall, PA 18052

Toll Free: 888-854-6895
Phone: 610-295-5321
Whitehall Law Office Map

Stroudsburg Office
706 Monroe St.
Stroudsburg, PA 18360

Stroudsburg Law Office Map

Call Us Today For A
Free Consultation